JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB76464

Anti-FGFR1 antibody [EPR806Y]

  • 20ul selling size
  • RabMAb
  • Recombinant
  • KO Validated
  • What is this?

5

(2 Reviews)

|

(46 Publications )

Anti-FGFR1 antibody [EPR806Y] (ab76464) is a rabbit monoclonal antibody detecting FGFR1 in Western Blot, IP, ICC/IF. Suitable for Human.

- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 30 publications
- Trusted since 2009
5 Images
Immunocytochemistry/ Immunofluorescence - Anti-FGFR1 antibody [EPR806Y] (AB76464)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-FGFR1 antibody [EPR806Y] (AB76464)

Immunofluorescent analysis of 4% Paraformaldehyde-fixed 0.1% TritonX-100 permeabilized SH-SY5Y (Human neuroblastoma epithelial cell) cells labelling FGFR1 with at 1/100 dilution followed by ab150077 AlexaFluor®488 Goat anti-Rabbit secondary antibody at 1/1000 dilution (Green). Confocal image showing cytoplasmic and weak nuclear staining in SH-SY5Y cell line is observed. ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) was used to counterstain tubulin at 1/200 dilution (Red). The Nuclear counterstain was DAPI (Blue).

Secondary antibody only control : Used PBS instead of primary antibody secondary antibody is ab150077 AlexaFluor®488 Goat anti-Rabbit secondary at 1/1000 dilution.

Immunoprecipitation - Anti-FGFR1 antibody [EPR806Y] (AB76464)
  • IP

Lab

Immunoprecipitation - Anti-FGFR1 antibody [EPR806Y] (AB76464)

ab76464 (purified) at 1/190 immunoprecipitating FGFR1 in 10 μg A-204 (Human muscle rhabdomyosarcoma)whole cell lysate (Lanes 1 and 2, observed at 145 kDa). Lane 3 - Rabbit monoclonal IgG (ab172730) instead of ab76464 in A-204 whole cell lysate. For western blotting, ab76464 at 1/500 and VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/1000 dilution.

Blocking/Dilution buffer and concentration : 5% NFDM/TBST.

All lanes:

Immunoprecipitation - Anti-FGFR1 antibody [EPR806Y] (ab76464)

Predicted band size: 92 kDa

false

Western blot - Anti-FGFR1 antibody [EPR806Y] (AB76464)
  • WB

Lab

Western blot - Anti-FGFR1 antibody [EPR806Y] (AB76464)

Lane 1 : Wild type HAP1 whole cell lysate (20 μg)
Lane 2 : FGFR1 knockout HAP1 whole cell lysate (20 μg)
Lane 3 : MCF7 whole cell lysate (20 μg)
Lane 4 : SH-SY5Y whole cell lysate (20 μg)

Lanes 1 - 4 : Merged signal (red and green). Green - ab76464 observed at 140 kDa. Red - loading control, ab8245, observed at 37 kDa.

ab76464 was shown to specifically react with FGFR1 when FGFR1 knockout samples were used. Wild-type and FGFR1 knockout samples were subjected to SDS-PAGE. ab76464 and ab8245 (Mouse anti GAPDH loading control) were incubated overnight at 4°C at 1 μg/mL and 1/10000 dilution respectively. Blots were developed with 800CW Goat anti Rabbit and 680CW Goat anti Mouse secondary antibodies at 1/10000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-FGFR1 antibody [EPR806Y] (ab76464)

Predicted band size: 92 kDa

false

Western blot - Anti-FGFR1 antibody [EPR806Y] (AB76464)
  • WB

Lab

Western blot - Anti-FGFR1 antibody [EPR806Y] (AB76464)

Western blot : Anti-FGFR1 antibody [EPR806Y] (ab76464) staining at 1/500 dilution, shown in green; Mouse anti-CANX [CANX/1543] (ab238078) loading control staining at 1/20000 dilution, shown in magenta. In Western blot, ab76464 was shown to bind specifically to FGFR1. A band was observed at 92 kDa in wild-type U-87 MG cell lysates with no signal observed at this size in FGFR1 knockout cell line. To generate this image, wild-type and FGFR1 knockout U-87 MG cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.

All lanes:

Western blot - Anti-FGFR1 antibody [EPR806Y] (ab76464) at 1/500 dilution

Lane 1:

Wild-type U-87 MG cell lysate at 20 µg

Lane 2:

FGFR1 knockout U-87 MG cell lysate at 20 µg

Secondary

All lanes:

Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution

Observed band size: 92 kDa

false

Western blot - Anti-FGFR1 antibody [EPR806Y] (AB76464)
  • WB

Lab

Western blot - Anti-FGFR1 antibody [EPR806Y] (AB76464)

Blocking/Dilution buffer and concentration : 5% NFDM/TBST.

All lanes:

Western blot - Anti-FGFR1 antibody [EPR806Y] (ab76464) at 1/500 dilution

All lanes:

SH-SY5Y (Human neuroblastoma cell line from bone marrow) cell lysate at 10 µg

Secondary

All lanes:

Peroxidase-conjugated goat anti-rabbit IgG (H+L) at 1/1000 dilution

Predicted band size: 92 kDa

Observed band size: 145 kDa

false

  • Carrier free

    Anti-FGFR1 antibody [EPR806Y] - Low endotoxin, Azide free

  • Carrier free

    Anti-FGFR1 antibody [EPR806Y] - BSA and Azide free

  • 660 APC

    APC Anti-FGFR1 antibody [EPR806Y]

  • 519 Alexa Fluor® 488

    Alexa Fluor® 488 Anti-FGFR1 antibody [EPR806Y]

  • 565 Alexa Fluor® 555

    Alexa Fluor® 555 Anti-FGFR1 antibody [EPR806Y]

  • 617 Alexa Fluor® 594

    Alexa Fluor® 594 Anti-FGFR1 antibody [EPR806Y]

  • 665 Alexa Fluor® 647

    Alexa Fluor® 647 Anti-FGFR1 antibody [EPR806Y]

  • 578 PE

    PE Anti-FGFR1 antibody [EPR806Y]

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR806Y

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

IP, WB, ICC/IF

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/190", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/100", "ICCIF-species-notes": "<p></p>" } } }

Product details

What is this antibody validated in?
Anti-FGFR1 antibody [EPR806Y] (ab76464) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Immunoprecipitation (IP), Immunocytochemistry/immunofluorescence (ICC/IF) in Human samples.

What is the molecular weight of FGFR1?
Anti-FGFR1 [EPR806Y] (ab76464) specifically detects a band for FGFR1 (UniProt: P11362) at a molecular weight of 92kDa.

Trusted by the scientific community
Anti-FGFR1 [EPR806Y] (ab76464) was first used in a scientific publication in 2009 and has been cited over 30 times in peer-reviewed journals.

Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.

Specificity confirmed
The specificity of Anti-FGFR1 antibody [EPR806Y] (ab76464) has been confirmed by Western blot testing in FGFR1 Knockout HAP1 cells.

Other related products
We have a range of other formats of antibody clone [EPR806Y] also available for your convenience: ab76464, Carrier free - ab206382, Carrier free - ab271861, Alexa Fluor® 488 - ab320422, Alexa Fluor® 647 - ab320423, Alexa Fluor® 555 - ab320424, Alexa Fluor® 594 - ab320425, PE - ab320426, APC - ab320427

Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Conditional Ambient
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

FGFR1 also known as fibroblast growth factor receptor 1 is a protein with a molecular weight of approximately 92 kDa. It is a receptor tyrosine kinase that binds to fibroblast growth factors (FGFs) triggering a cascade of downstream signaling pathways. FGFR1 is widely expressed in various tissues including the brain skeletal muscle and the cardiovascular system. The FGFR1 protein plays an essential role in cellular processes such as proliferation differentiation and survival.
Biological function summary

FGFR1 is significant in embryonic development and tissue repair. It does not function alone; rather it forms a complex with fibroblast growth factors and heparan sulfate proteoglycans facilitating receptor dimerization and autophosphorylation. FGFR1 is involved in bone growth angiogenesis and wound healing processes. The interaction of FGFR1 with these complex factors ensures the precise regulation of these critical physiological events in the body.

Pathways

FGFR1 participates actively in the MAPK/ERK and PI3K/AKT signaling pathways. These pathways are vital for transmitting signals from the cell surface to the DNA in the cell nucleus regulating gene expression and affecting cell cycle progression. FGFR1 works alongside similar proteins like FGFR2 influencing cell fate decisions. By modulating these pathways FGFR1 ensures a proper response to environmental signals which maintains homeostasis and adapts to physiological needs.

FGFR1 is implicated in conditions such as cancer and skeletal dysplasias. Abnormal FGFR1 signaling due to mutations or overexpression can lead to tumorigenesis contributing to the development of cancers like breast and lung cancer. The protein FGFR2 is often evaluated in parallel for similar oncogenic activities. Moreover FGFR1-related dysregulation in bone development can result in skeletal disorders highlighting its importance in both normal physiology and pathological conditions. Anti-FGFR therapies and FGFR1 ELISA tools are being explored to better understand and tackle these diseases.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Tyrosine-protein kinase that acts as a cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of embryonic development, cell proliferation, differentiation and migration. Required for normal mesoderm patterning and correct axial organization during embryonic development, normal skeletogenesis and normal development of the gonadotropin-releasing hormone (GnRH) neuronal system. Phosphorylates PLCG1, FRS2, GAB1 and SHB. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Promotes phosphorylation of SHC1, STAT1 and PTPN11/SHP2. In the nucleus, enhances RPS6KA1 and CREB1 activity and contributes to the regulation of transcription. FGFR1 signaling is down-regulated by IL17RD/SEF, and by FGFR1 ubiquitination, internalization and degradation.
See full target information FGFR1

Alternative Names

CD331, BFGFR, CEK, FGFBR, FLG, FLT2, HBGFR, FGFR1, Fibroblast growth factor receptor 1, FGFR-1, Basic fibroblast growth factor receptor 1, Fms-like tyrosine kinase 2, N-sam, Proto-oncogene c-Fgr, bFGF-R-1, FLT-2

Publications (46)

Recent publications for all applications. Explore the full list and refine your search

Communications biology 8:1185 PubMed40781553

2025

Exploiting collateral sensitivity in the evolution of resistance to tyrosine kinase inhibitors in soft tissue sarcomas.

Applications

Unspecified application

Species

Unspecified reactive species

Mark L Elms,Andrew D Jenks,Avirup Chowdhury,Lukas Krasny,Madhumeeta Chadha,Kaan Low,Peter T Harrison,William G Kerrison,Robin L Jones,Paul H Huang

Acta pharmaceutica Sinica. B 15:2156-2169 PubMed40486834

2025

GPC3-mediated lysosome-targeting chimeras (GLTACs) for targeted degradation of membrane proteins.

Applications

Unspecified application

Species

Unspecified reactive species

Yuxin Fang,Yaojin Zhu,Wei Wang,Zhewei Xia,Shipeng He,Guoqiang Dong,Chunquan Sheng

Journal of experimental & clinical cancer research : CR 44:11 PubMed39794830

2025

PRMT5 inhibition has a potent anti-tumor activity against adenoid cystic carcinoma of salivary glands.

Applications

Unspecified application

Species

Unspecified reactive species

Vasudha Mishra,Alka Singh,Michael Korzinkin,Xiangying Cheng,Claudia Wing,Viktoria Sarkisova,Ashwin L Koppayi,Alexandra Pogorelskaya,Oksana Glushchenko,Manu Sundaresan,Venkat Thodima,Jack Carter,Koichi Ito,Peggy Scherle,Anna Trzcinska,Ivan Ozerov,Everett E Vokes,Grayson Cole,Frank W Pun,Le Shen,Yuxuan Miao,Alexander T Pearson,Mark W Lingen,Bruce Ruggeri,Ari J Rosenberg,Alex Zhavoronkov,Nishant Agrawal,Evgeny Izumchenko

Journal of Cancer 15:5415-5424 PubMed39247610

2024

STAT3 inhibitor Stattic Exhibits the Synergistic Effect with FGFRs Inhibitor Erdafitinib in FGFR1-positive Lung Squamous Cell Carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Hongqin Zhong,Ling Wang,Xue Zhu,Shu Li,Xiyue Li,Chen Ding,Ke Wang,Xun Wang

Cell death & disease 15:279 PubMed38637504

2024

Cancer-associated fibroblasts secrete FGF5 to inhibit ferroptosis to decrease cisplatin sensitivity in nasopharyngeal carcinoma through binding to FGFR2.

Applications

Unspecified application

Species

Unspecified reactive species

Feng Liu,Ling Tang,Huai Liu,Yanzhu Chen,Tengfei Xiao,Wangning Gu,Hongmin Yang,Hui Wang,Pan Chen

The Journal of clinical investigation 133: PubMed37606995

2023

Somatic rearrangements causing oncogenic ectodomain deletions of FGFR1 in squamous cell lung cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Florian Malchers,Lucia Nogova,Martijn Ha van Attekum,Lukas Maas,Johannes Brägelmann,Christoph Bartenhagen,Luc Girard,Graziella Bosco,Ilona Dahmen,Sebastian Michels,Clare E Weeden,Andreas H Scheel,Lydia Meder,Kristina Golfmann,Philipp Schuldt,Janna Siemanowski,Jan Rehker,Sabine Merkelbach-Bruse,Roopika Menon,Oliver Gautschi,Johannes M Heuckmann,Elisabeth Brambilla,Marie-Liesse Asselin-Labat,Thorsten Persigehl,John D Minna,Henning Walczak,Roland T Ullrich,Matthias Fischer,Hans Christian Reinhardt,Jürgen Wolf,Reinhard Büttner,Martin Peifer,Julie George,Roman K Thomas

Nature communications 14:4467 PubMed37491377

2023

Circular RNA encoded MET variant promotes glioblastoma tumorigenesis.

Applications

Unspecified application

Species

Unspecified reactive species

Jian Zhong,Xujia Wu,Yixin Gao,Junju Chen,Maolei Zhang,Huangkai Zhou,Jia Yang,Feizhe Xiao,Xuesong Yang,Nunu Huang,Haoyue Qi,Xiuxing Wang,Fan Bai,Yu Shi,Nu Zhang

Advanced science (Weinheim, Baden-Wurttemberg, Germany) 10:e2302677 PubMed37387563

2023

Small Extracellular Vesicle-Derived vWF Induces a Positive Feedback Loop between Tumor and Endothelial Cells to Promote Angiogenesis and Metastasis in Hepatocellular Carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Samuel Wan Ki Wong,Sze Keong Tey,Xiaowen Mao,Hiu Ling Fung,Zhi-Jie Xiao,Danny Ka Ho Wong,Lung-Yi Mak,Man-Fung Yuen,Irene Oi-Lin Ng,Jing Ping Yun,Yi Gao,Judy Wai Ping Yam

Oncology research 29:189-200 PubMed37304675

2023

Long noncoding RNA CCDC183-AS1 depletion represses breast cancer cell proliferation, colony formation, and motility by sponging microRNA-3918.

Applications

Unspecified application

Species

Unspecified reactive species

Tao Liu,Limin Zhou,Lianbo Zhang,Xin Guan,Y I Dong

iScience 26:106573 PubMed37138777

2023

LBP1C-2 from maintains skeletal muscle satellite cell pool by interaction with FGFR1.

Applications

Unspecified application

Species

Unspecified reactive species

Jiao Meng,Zhenyu Lv,Xia Chen,Chuanxin Sun,Can Jin,Kan Ding,Chang Chen
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com